Pro-Life Group Wants FDA Commissioner Marty Makary Fired for Ignoring Abortion Drug Problems

Susan B. Anthony Pro-Life America is calling for the immediate removal of FDA Commissioner Marty Makary following The Wall Street Journal’s report of the commissioner’s “indifference” to deadly abortion drugs. The drugs have killed millions of unborn children and sent countless women to emergency rooms across the country with serious complications, according to internal statements that contradict months of public assurances that the study was well underway in the “data acquisition” phase. The newly reported statements support prior reporting that the study is being slow-walked for political reasons.

Click Like if you are pro-life to like the LifeNews Facebook page!

In October, as the FDA approved a new generic version of mifepristone, the Journal reports Makary stated “I don’t think about” urgently-needed safety regulations on abortion drugs, describing his posture as indifferent:

For months, the administration said the new safety study was coming, and Makary has said publicly that his agency is working on the data acquisition needed to finish the review. But privately, the FDA commissioner has told others in the administration that he can’t produce the study until a new drug-safety data-monitoring system, known as Sentinel 3.0, is up and running, people familiar with the matter said.

Makary has argued current systems are inadequate to the task—a claim some FDA staff dispute. The FDA hasn’t yet finished the lengthy process of finding a contractor to run the new system, which might not be ready to use until late 2026 or even 2027, some of the people said.

Abortion drugs are sending women and girls to emergency rooms, with as many as 11% suffering serious adverse effects like hemorrhaging, infection, sepsis, and even death.  According to the Charlotte Lozier Institute, 75% of visits from women who went to the ER after taking abortion drugs were coded as severe or critical.

SBA Pro-Life America President Marjorie Dannenfelser issued the following statement:

“FDA Commissioner Makary should be fired immediately. Indifference is completely unacceptable to millions of pro-life voters expecting the administration to act to save lives. Abortions are up, not down after Dobbs, with at least 1.1 million deaths a year. More than 90,000 abortions occur each year just in states that protect babies in the law throughout all nine months of pregnancy – a direct result of Biden’s Covid-era mail-order abortion drug rule, which the Trump administration inexplicably allows to continue.

“Without basic in-person medical supervision, male buyers have a frighteningly easy tool to abuse women like abortion drug coercion survivor Rosalie Markezich and their children. The Supreme Court will now decide whether this injustice ends here, or whether it raises its ugly head over and over again.

“This is a five-alarm crisis for the pro-life movement and for the GOP. The ‘states-only’ strategy, promoted out of fear after Dobbs, is an abject failure in the face of blue states brazenly violating state sovereignty and nullifying hard-won pro-life gains. The GOP cannot win without its base and simply will not get the enthusiasm that drives turnout without leadership from the top. With one third of the most engaged primary voters sidelined and unheard, the Trump administration’s inaction puts lives and voter morale at risk every day longer it goes on.”

On Friday the 5th U.S. Circuit Court of Appeals granted abortion drug coercion survivor Rosalie Markezich’s and the State of Louisiana’s request to halt the agency’s Biden/Covid-era policy allowing mail-order abortion drugs – effective immediately – while their lawsuit (Louisiana v. FDA) moves forward, finding that they are likely to succeed on the merits. The U.S. Supreme Court on Monday morning put an administrative stay on the 5th Circuit decision for one week while the parties respond to abortion drug manufacturer Danco Laboratories’ appeal.

The lawsuit is one of several cases brought by pro-life states that the Trump administration has sought to dismiss. Nearly 80 pro-life groups led by SBA Pro-Life America recently sent a letter to acting U.S. Attorney General Todd Blanche urging the Department of Justice to stop siding with the abortion drug industry against pro-life states.

The post Pro-Life Group Wants FDA Commissioner Marty Makary Fired for Ignoring Abortion Drug Problems appeared first on LifeNews.com.